Welcure Drugs & Pharmaceuticals Ltd

Welcure Drugs Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Welcure Drugs & Pharmaceuticals Ltd

₹ 0.29 0.00%
29 May - close price
Company website BSE: 524661
About

Incorporated in 1992, Welcure Drugs and Pharmaceuticals Ltd is in the business of pharmaceutical and healthcare.[1]

Key Points

Business Overview:[1]
WDPL is engaged in the manufacture and
trade of a wide range of healthcare formulations.

Website BSE
  • Market Cap ₹ 35.8 Cr.
  • Current Price ₹ 0.29
  • High / Low ₹ 1.45 / 0.23
  • Stock P/E
  • Book Value ₹ 0.78
  • Dividend Yield 0.00 %
  • ROCE -3.40 %
  • ROE -5.50 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Stock is trading at 0.37 times its book value

Cons

  • Company has low interest coverage ratio.
  • Company has a low return on equity of -2.28% over last 3 years.
  • Company has high debtors of 213 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
0 0 0 0 0 0 25 1 21 300 66 0 0
0 0 0 0 0 0 23 1 21 269 54 0 50
Operating Profit -0 -0 -0 -0 -0 -0 2 0 1 31 11 -0 -50
OPM % 7% 10% 3% 10% 17%
0 0 0 0 0 0 0 0 2 0 0 1 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0 0
Profit before tax 0 -0 -0 -0 -0 -0 2 0 3 31 11 1 -50
Tax % 0% 0% 0% 0% 0% 0% 0% 56% 0% 25% 25% 25% 0%
0 -0 -0 -0 -0 -0 2 0 3 23 8 1 -50
EPS in Rs 0.01 -0.00 -0.01 -0.00 -0.00 -0.02 0.01 0.00 0.02 0.19 0.07 0.01 -0.40
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
0 0 0 0 0 0 0 0 0 0 25 366
0 0 0 0 0 0 0 0 0 0 24 372
Operating Profit 0 0 0 -0 0 -0 0 0 -0 -0 1 -7
OPM % 20% 40% 33% -40% 0% -12% 46% 18% 4% -2%
0 0 0 0 0 0 0 0 0 0 2 1
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0
Profit before tax 0 0 0 -0 0 -0 0 0 0 -0 3 -5
Tax % 0% 0% 0% 0% 0% 0% 0% 0% 0% 22% 0%
0 0 0 -0 0 -0 0 0 0 -0 2 -5
EPS in Rs 0.00 0.01 0.00 -0.00 0.00 -0.00 0.00 0.00 0.01 -0.01 0.02 -0.04
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 127%
5 Years: 390%
3 Years: %
TTM: 1389%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -353%
Stock Price CAGR
10 Years: 9%
5 Years: 5%
3 Years: -7%
1 Year: -72%
Return on Equity
10 Years: -2%
5 Years: -2%
3 Years: -2%
Last Year: -6%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 12 12 12 12 12 12 12 12 13 13 112 124
Reserves -12 -12 -12 -12 -12 -12 -12 -12 -12 -12 -10 -27
0 0 0 0 0 0 0 0 0 0 123 0
0 0 0 0 0 0 0 0 0 0 41 413
Total Liabilities 0 0 0 0 0 0 0 0 2 1 267 510
0 0 0 0 0 0 0 0 0 0 0 0
CWIP 0 0 0 0 0 0 0 0 0 0 0 0
Investments 0 0 0 0 0 0 0 0 0 0 0 1
0 0 0 0 0 0 0 0 1 1 267 509
Total Assets 0 0 0 0 0 0 0 0 2 1 267 510

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
0 -0 0 -0 0 -0 0 0 0 -0 -222
0 0 0 0 0 0 0 0 0 0 -0
0 0 0 0 0 0 0 0 -0 -0 222
Net Cash Flow 0 -0 0 -0 0 -0 0 0 -0 0 0
Free Cash Flow 0 -0 0 -0 0 -0 0 0 0 -0 -222
CFO/OP 100% -125% 67% 50% 100% 67% 100% -79% 57% -22,890%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 0 0 0 0 0 0 0 0 282 213
Inventory Days 2,554 162
Days Payable 52 226
Cash Conversion Cycle 0 0 0 0 0 0 0 0 2,784 150
Working Capital Days -876 36 81 73 46 0 0 0 2,092 -56
ROCE % 120% -67% 0% -40% 133% 25% 10% -13% 3% -3%

Insights

In beta
Mar 2012 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Domestic Sales Volume (Recognized Orders)
INR Crore

Log in to view insights

Please log in to see hidden values.

Login

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

12 Recently
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
100.00% 100.00% 99.99% 100.00% 100.00% 100.00% 100.00% 99.98% 99.99% 99.99% 100.00% 100.00%
No. of Shareholders 29,25129,59329,95731,53031,04530,21830,60532,36637,29876,95487,28887,977

Documents

Announcements

Annual reports